Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues
PaperCitations, authors & open-access status
Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 209 citations, 2015 year and gold oa status.
209
Citations
2015
Year
gold
OA Status